“Retrospective Evaluation of the Analgesic Effects of Molecular Target Agents Against Cancer Pain and Oxaliplatin-Induced Chronic Peripheral Neuropathy”, J. Anal. Oncol., vol. 11, pp. 40–44, Oct. 2022, doi: 10.30683/1927-7229.2022.11.06.